← Back to Search

Risk Information for Colorectal Cancer (CRC45+TEXT Trial)

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
UCLA Health patient
Age 45-49 (as of 2/1/2022)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week after getting the initial text message
Awards & highlights

CRC45+TEXT Trial Summary

This trial is aimed at finding the best way to get people aged 45-49 to get screened for colorectal cancer.

Eligible Conditions
  • Colorectal Cancer

CRC45+TEXT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

CRC45+TEXT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week after getting the initial text message
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after getting the initial text message for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opening link within SMS Text message
Secondary outcome measures
CRC45+ Choice MyChart Message opened
Opening link within SMS Text Message
Overall completion of any CRC screening test

CRC45+TEXT Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: "Risk Information"Experimental Treatment1 Intervention
This group will receive an SMS text message highlighting their risk for CRC.
Group II: "Risk Information + Action"Experimental Treatment1 Intervention
This group will receive an SMS message highlighting their risk for CRC and the importance of taking quick action.
Group III: Standard of CareActive Control1 Intervention
This group will receive a standard SMS text message indicating that they have a MyChart message from their provider about CRC screening and should follow a link to be screened.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Risk Information
2022
N/A
~20510
Risk Information + Action
2022
N/A
~20510

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,521 Previous Clinical Trials
10,258,427 Total Patients Enrolled
UCLA Vatche and Tamar Manoukian Division of Digestive DiseasesUNKNOWN
2 Previous Clinical Trials
24,389 Total Patients Enrolled
UCLA Anderson School of ManagementUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6652 spots leftby Mar 2025